Silver

NutraPedia - Evidence-Based Supplement Research

Back to Table of Contents
Health Goals: immunity skin detox

Research Overview

Across the reviewed studies, research on silver—especially silver nanoparticles (AgNPs, typically 1–100 nm)—is most heavily concentrated in biomedicine and nanomedicine. The dominant themes are (i) antimicrobial and antibiofilm applications (including hospital-relevant multidrug-resistant organisms), (ii) antiviral activity and incorporation into devices (e.g., filtration, coatings, textiles), (iii) anticancer potential (as direct cytotoxins and as photosensitizers/radiosensitizers or drug-delivery enhancers), and (iv) synthesis/engineering strategies, including physicochemical characterization (e.g., surface plasmon resonance/LSPR) and “green” biological synthesis using plant extracts or microorganisms. A parallel, substantial literature addresses toxicology, environmental release, and the emergence/spread of bacterial silver-resistance determinants, including their association with mobile genetic elements.

The strongest and most consistently supported evidence in these summaries is for broad-spectrum antimicrobial activity of silver ions and AgNPs, with repeated mechanistic motifs including membrane disruption, oxidative stress, and downstream cellular damage. There is also convergent evidence that AgNP performance is highly dependent on controllable parameters—size, shape, surface functionalization, and concentration—which influence interactions with microbes and viruses and determine device-level utility. For oncology, the studies collectively support plausible anticancer mechanisms (e.g., apoptosis induction, angiogenesis inhibition) and enabling roles (e.g., radiosensitization/photosensitization, drug-delivery enhancement), but the emphasis remains largely on preclinical promise rather than established clinical efficacy. Similarly, antiviral effects are repeatedly reported across diverse viruses, with evidence pointing to interference with early virus–host interactions and possible direct virucidal activity, though mechanisms are described as not fully clarified.

Key areas needing more research include: (i) standardized, comparative toxicology and pharmacokinetics across AgNP formulations to resolve dose–response relationships, long-term exposure risks, and organ-specific effects; (ii) clearer mechanistic delineation separating particle-specific effects from released Ag+ contributions; (iii) rigorous translational studies for cancer and antiviral indications (well-controlled in vivo studies, clinically relevant endpoints, and ultimately clinical trials) to substantiate therapeutic benefit relative to toxicity; and (iv) environmental fate, transport, and ecosystem impacts under realistic release scenarios, including how widespread use may select for and disseminate silver resistance and potential co-selection with antibiotic resistance. Regulatory frameworks and reproducible manufacturing (including green synthesis scalability and batch-to-batch consistency) are also highlighted as necessary to move from laboratory demonstrations to safe, effective, and controllable real-world applications.

1. What conditions has Silver been studied for?

  • Wound care and burns: Silver-containing dressings (including nanocrystalline silver) and silver as an adjunct to negative-pressure wound therapy; silver sulfadiazine specifically discussed for burns.

  • Infections (including multidrug-resistant organisms): Silver ions and silver nanoparticles (AgNPs) as antimicrobials, including use alongside antibiotics for synergistic effects against MDR pathogens.

  • Viral infections (antiviral applications): AgNPs studied against a wide range of viruses; applications include biomedical devices, filtration, and other settings.

  • Cancer (primarily nanoparticle-based approaches): AgNPs explored as anticancer agents (e.g., leukemia, breast cancer, hepatocellular carcinoma, lung cancer, skin/oral carcinoma) via mechanisms such as apoptosis induction, angiogenesis inhibition, and drug delivery enhancement; also as photosensitizers/radiosensitizers.

  • Dentistry: Silver compounds (e.g., silver nitrate, silver fluoride, silver diamine fluoride) for prevention/arrest of dental caries; also studied for dentine desensitization, root canal disinfection, and incorporation into restorative materials.

  • Medical devices/implants and tissue repair (preclinical/biomaterials context): Reviews describe AgNPs in dentistry/dental implants, cardiovascular implants, bone healing promotion, and wound healing materials.

  • Environmental/agricultural applications (not human treatment): Plant-pathogen control, water treatment, and nano-agrochemicals; also plant/soil accumulation concerns.

2. Does it work in treating those conditions? Summarize the evidence.

  • Infected wounds: A qualitative analysis of 59 studies concluded there is some evidence supporting short-term use of nanocrystalline silver dressings in infected wounds, but overall research quality was described as poor and heterogeneous. It also concluded silver is beneficial for the first days/weeks in infected wounds, after which nonsilver dressings should be used.

  • Clean wounds and closed surgical incisions: The same wound-care review concluded silver-containing dressings are not indicated for clean wounds or over closed surgical incisions (i.e., no demonstrated benefit in those contexts).

  • Burns: The wound-care review concluded silver sulfadiazine slows healing and should not be used for burns; it reported that nanocrystalline silver (and alternatives like octenidine/polyhexanide) are associated with less infection and faster healing than silver sulfadiazine.

  • Negative-pressure wound therapy (NPWT): The wound-care review reported NPWT accelerates healing of contaminated wounds, especially when silver is used as an adjunct (suggesting additive benefit in that specific setting).

  • Dental caries: A dentistry review (1966–2011 plus older hand-searching) reported in vitro, in vivo, and clinical evidence that silver compounds are viable agents for preventing and arresting caries in primary and permanent teeth, though it noted incomplete understanding of mechanisms and adverse effects (e.g., discoloration).

  • Antibiotic synergy for MDR infections: A review described “recent studies” showing that controlled silver ion release can enhance the efficacy of common antibiotics, attributing this to the energetic burden of bacterial responses to silver that weakens metabolism and defenses. However, the study does not specify clinical trial outcomes, so the strength of evidence (preclinical vs clinical) cannot be fully determined from the study alone.

  • Antiviral effects: Reviews state AgNPs have been demonstrated effective against a wide range of viruses and may act on viruses and early host-cell interaction steps, but also emphasize the mechanism is not completely clarified and activity depends on factors like size, shape, functionalization, and concentration. The studies do not provide clinical efficacy outcomes.

  • Cancer therapy: Multiple reviews describe AgNPs as having “remarkable potential” and “newly emerging applications” in cancer therapy (apoptosis induction, angiogenesis inhibition, drug delivery enhancement; possible photo/radiosensitization). However, these are largely review-level claims and the studies do not cite definitive human clinical benefit; they also highlight translational barriers and toxicity concerns.

3. What health benefits does it have?

  • Antimicrobial activity: Silver ions and AgNPs are repeatedly described as having strong antimicrobial properties, including potential utility against MDR pathogens and possible synergy with antibiotics (via controlled ion release).

  • Wound infection control (short-term, specific formulations): Evidence supports short-term use of nanocrystalline silver in infected wounds, and silver as an adjunct in NPWT for contaminated wounds (per the qualitative wound-care review).

  • Dental caries prevention/arrest: Silver compounds have clinical evidence supporting prevention and arrest of caries in both primary and permanent dentition (with known trade-offs such as discoloration).

  • Potential antiviral applications: AgNPs have demonstrated antiviral activity in research settings, with proposed mechanisms involving direct viral effects and interference with early infection steps; applicability spans biomedical devices and environmental controls (e.g., filtration), though clinical treatment benefit is not established in these studies.

  • Potential anticancer applications (experimental): Reviews describe anticancer mechanisms (e.g., apoptosis induction, angiogenesis inhibition, drug delivery enhancement; photo/radiosensitization), but these benefits remain largely investigational based on the studies reviewed here.

4. Does it have any downsides or side effects?

  • Impaired wound healing/cytotoxicity risk: Silver can impair healing by toxic effects on keratinocytes and fibroblasts (wound-care review), highlighting the importance of formulation, dose, and duration.

  • Burn treatment downside (silver sulfadiazine): The wound-care review concluded silver sulfadiazine slows healing and should not be used for burns.

  • Nanoparticle toxicity and translational concerns: Multiple reviews emphasize toxicity concerns, immunogenicity, and regulatory/translational barriers for nanoparticle-based applications; one review notes AgNP risk is “not yet clarified.”

  • Dental adverse effects: Silver compounds for caries are associated with tooth discoloration and there are reports of possible pulp irritation (dentistry review).

  • Resistance and ecological downsides: A review highlights that silver resistance determinants are widely spread among environmental and clinically relevant bacteria and are often on mobile genetic elements, facilitating spread. Widespread use may increase environmental release with potential ecosystem impacts.

  • Evidence quality limitations: The wound-care review explicitly states the literature is heterogeneous and overall quality is poor, limiting confidence and making guideline generation difficult.

5. Is it beneficial or harmful for any genetic variations (pharmacogenomics)?

The studies reviewed here do not describe specific human genetic variants that predict benefit or harm from silver (ions, silver compounds, or silver nanoparticles). No pharmacogenomic markers are identified for response, toxicity, or dosing.

  • What is discussed instead: Variation in effects is repeatedly linked to nanoparticle properties (size, shape, functionalization, concentration) and to formulation choice (e.g., nanocrystalline silver vs silver sulfadiazine), rather than patient genetics.

  • Practical implication: Based on these studies alone, silver use cannot be tailored using pharmacogenomics; risk/benefit decisions rely more on indication (infected vs clean wounds), formulation, duration, and toxicity considerations.

References

  1. Advanced Nanomaterials for Cancer Therapy: Gold, Silver, and Iron Oxide Nanoparticles in Oncological Applications.
    Priyanka Singh, Santosh Pandit, Sri Renukadevi Balusamy, Mukil Madhusudanan, Hina Singh, H Mohamed Amsath Haseef, Ivan Mijakovic (2025) - Advanced healthcare materials
  2. Silver nanoparticles: synthesis, properties, and therapeutic applications.
    Liuya Wei, Jingran Lu, Huizhong Xu, Atish Patel, Zhe-Sheng Chen, Guofang Chen (2015) - Drug discovery today
  3. Silver Nanoparticles: Review of Antiviral Properties, Mechanism of Action and Applications.
    Angelica Luceri, Rachele Francese, David Lembo, Monica Ferraris, Cristina Balagna (2023) - Microorganisms
  4. Antimicrobial silver: uses, toxicity and potential for resistance.
    Kristel Mijnendonckx, Natalie Leys, Jacques Mahillon, Simon Silver, Rob Van Houdt (2013) - Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine
  5. Green Synthesis of Gold and Silver Nanoparticles from Plant Extracts and Their Possible Applications as Antimicrobial Agents in the Agricultural Area.
    Luis Castillo-Henríquez, Karla Alfaro-Aguilar, Jeisson Ugalde-Álvarez, Laura Vega-Fernández, Gabriela Montes de Oca-Vásquez, José Roberto Vega-Baudrit (2020) - Nanomaterials (Basel, Switzerland)
  6. Silver nanoparticles: synthesis, characterisation and biomedical applications.
    Ahmad Almatroudi (2020) - Open life sciences
  7. Pharmaceutical aspects of silver nanoparticles.
    Prateek Mathur, Swati Jha, Suman Ramteke, N K Jain (2018) - Artificial cells, nanomedicine, and biotechnology
  8. Silver Nanoparticles in Therapeutics and Beyond: A Review of Mechanism Insights and Applications.
    Furkan Eker, Hatice Duman, Emir Akdaşçi, Anna Maria Witkowska, Mikhael Bechelany, Sercan Karav (2024) - Nanomaterials (Basel, Switzerland)
  9. Silver Nanoparticles and Antibiotics: A Promising Synergistic Approach to Multidrug-Resistant Infections.
    Eudald Casals, Muriel F Gusta, Neus Bastus, Jordi Rello, Victor Puntes (2025) - Microorganisms
  10. Silver in Wound Care-Friend or Foe?: A Comprehensive Review.
    Ibrahim Khansa, Anna R Schoenbrunner, Casey T Kraft, Jeffrey E Janis (2019) - Plastic and reconstructive surgery. Global open
  11. Silver compounds used in dentistry for caries management: a review.
    J J-Y Peng, M G Botelho, J P Matinlinna (2012) - Journal of dentistry
  12. Carbohydrate polymer-based silver nanocomposites: Recent progress in the antimicrobial wound dressings.
    Mahdi Rahimi, Ehsan Bahojb Noruzi, Elham Sheykhsaran, Baharin Ebadi, Zahra Kariminezhad, Morteza Molaparast, Mojtaba Ghanbari Mehrabani, Bahareh Mehramouz, Mehdi Yousefi, Raman Ahmadi, Bahman Yousefi, Khudaverdi Ganbarov, Fadhil S Kamounah, Vahid Shafiei-Irannejad, Hossein Samadi Kafil (2020) - Carbohydrate polymers
  13. Developing a New Generation of Antimicrobial and Bioactive Dental Resins.
    L Cheng, K Zhang, N Zhang, M A S Melo, M D Weir, X D Zhou, Y X Bai, M A Reynolds, H H K Xu (2017) - Journal of dental research
  14. Nano-silver functionalized polysaccharides as a platform for wound dressings: A review.
    Yucheng Yuan, Liangping Ding, Yang Chen, Guoqiang Chen, Tianbao Zhao, Yunlong Yu (2022) - International journal of biological macromolecules
  15. Evaluation of silver nanoparticles in cosmeceutical and potential biosafety complications.
    Wei Ting Jess Ong, Kar Lin Nyam (2022) - Saudi journal of biological sciences
  16. Amelioration Strategies for Silver Diamine Fluoride: Moving from Black to White.
    Amjad Almuqrin, Inder Preet Kaur, Laurence J Walsh, Chaminda Jayampath Seneviratne, Sobia Zafar (2023) - Antibiotics (Basel, Switzerland)
  17. Therapeutic gold, silver, and platinum nanoparticles.
    Miko Yamada, Matthew Foote, Tarl W Prow (2015) - Wiley interdisciplinary reviews. Nanomedicine and nanobiotechnology
  18. Silver Nanoparticles as Antimicrobial Agents in Veterinary Medicine: Current Applications and Future Perspectives.
    Thibault Frippiat, Tatiana Art, Catherine Delguste (2025) - Nanomaterials (Basel, Switzerland)
  19. Synergistic effect of plant extract coupled silver nanoparticles in various therapeutic applications- present insights and bottlenecks.
    Mahak Majeed, Khalid Rehman Hakeem, Reiaz Ul Rehman (2022) - Chemosphere
  20. Use of silver in the prevention and treatment of infections: silver review.
    Amani D Politano, Kristin T Campbell, Laura H Rosenberger, Robert G Sawyer (2013) - Surgical infections


Related

This article summarizes published research for educational purposes. It is not medical advice. Talk to your doctor before starting, stopping, or changing any supplement or medication.

Want personalized supplement recommendations based on your genetics?
Upload Whole Genome Sequencing (WGS) raw DNA data today!
Or upload raw DNA data to get started with your free analysis!